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New Guinea – a retrospective case review
Nancy N Hamura1*, John W Bolnga1, Regina Wangnapi2, Andrew W Horne3, Stephen J Rogerson4
and Holger W Unger4Abstract
Background: Ectopic pregnancy (EP) is an important cause of morbidity and mortality amongst women of
reproductive age. Tubal EP is well described in industrialised countries, but less is known about its impact in
low-resource countries, in particular in the South Pacific Region.
Methods: We undertook a retrospective review of women with tubal EP treated at a provincial referral hospital in
coastal Papua New Guinea over a period of 56 months. Demographic and clinical variables were obtained from
patients’ medical records and analysed. The institutional rate of tubal EP was calculated, and diagnosis and
management reviewed. Potential risk factors for tubal EP were identified, and delays contributing to increased
morbidity described.
Results: A total of 73 women had tubal EP. The institutional rate of tubal EP over the study period was 6.3 per
1,000 deliveries. There were no maternal deaths due to EP. The mean age of women was 31.5+/−5.7 years, 85%
were parous, 67% were rural dwellers and 62% had a history of sub-fertility. The most commonly used diagnostic
aid was culdocentesis. One third of women had clinical evidence of shock on arrival. All women with tubal EP were
managed by open salpingectomy. Tubal rupture was confirmed for 48% of patients and was more common
amongst rural dwellers. Forty-three percent of women had macroscopic evidence of pelvic infection. Two-thirds of
patients received blood transfusions, and post-operative recovery lasted six days on average. Late presentation, lack
of clinical suspicion, and delays with receiving appropriate treatments were observed.
Conclusions: Tubal EP is a common gynaecological emergency in a referral hospital in coastal PNG, and causes
significant morbidity, in particular amongst women residing in rural areas. Sexually transmitted infections are likely
to represent the most important risk factor for tubal EP in PNG. Interventions to reduce the morbidity due to tubal
EP include the prevention, detection and treatment of sexually transmitted infections, identification and reduction
of barriers to prompt presentation, increasing health workers’ awareness of ectopic pregnancy, providing pregnancy
test kits to rural health centres, and strengthening hospital blood transfusion services, including facilities for
autotransfusion.
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Ectopic pregnancy (EP) is the implantation of a
fertilised ovum outside the uterine cavity [1]. EP most
commonly occurs in the fallopian tubes (> 98%) [2]. If
left untreated, or diagnosed late, EP can result in intra-
abdominal haemorrhage and death [3]. In high-income
countries 1-2% of all pregnancies are EPs [2]. Their
incidence has risen, and they frequently represent the
leading cause of early maternal mortality [3,4]. Fallopian
tube damage secondary to surgery or genital tract infection
(in particular Chlamydia trachomatis), infertility and sub-
fertility, contraceptive failure, increased maternal age,
smoking, and a history of previous EP and miscarriage
are well-established risk factors for tubal EP [2]. In
well-resourced healthcare systems the wide availability
of, and access to, ultrasound, urine and serum β-
human chorionic gonadotrophin (β-HCG) tests, and
diagnostic laparoscopy facilitates diagnosis [2]. Most
tubal EPs are removed laparoscopically (provided the
patient is haemodynamically stable), with an increasing
number of unruptured tubal EPs treated medically [4].
Less is known about the burden and management of
EP in low and middle-income countries (LMICs). Re-
ports on the contribution of EP to maternal deaths
provide conflicting data: one meta-analysis estimates it is
< 1% [5], whereas other, mostly African, studies report it
is higher than in high-income countries [6-10]. In Asia,
mortality rates due to EP appear more homogenous and
are lower compared to Africa [7,10,11]. Given the pos-
sible shortcomings in documentation and reporting, as
well as the possibility of affected women not seeking or
reaching healthcare facilities, a clear consensus on the
incidence of EP and its relative contribution to maternal
morbidity and mortality in LMICs is lacking. Equally,
the use of different denominators for reporting EP rates
hinders comparison internationally (e.g. number of EP
per 1,000 deliveries, or per 10,000 women at reproduct-
ive age) [12]. Nevertheless, available data suggests EP is
a relatively common gynaecological emergency in
LMICs, its case fatality is high [7] and its incidence is
rising [6,7,13].
Risk factors associated with tubal EP in LMICs are
likely to be similar to those observed in industrialised
countries, although relative contributions may differ and
regional heterogeneity is likely to exist. Previous use of
assisted reproductive technology and contraceptive
failure are less commonly implicated in LMICs [9].
Chlamydial (and possibly Neisseria gonorrhoeae) infec-
tion and pelvic inflammatory disease may be more im-
portant [7,9,14-16], and so is smoking, given the
increasing number of women at reproductive age in
LMICs who use tobacco [17]. In addition, there are indi-
cations that tuberculosis and Schistosoma haematobium
infection may increase the risk of tubal EP [18-20].Behavioural and clinical risk factors include early sexual
debut, multiple lifetime sexual partners, lack of condom
use, miscarriage and induced abortion, and a history of
pelvic inflammatory disease (PID) and sexually transmit-
ted infection (STI) [9].
The most frequently used treatment modality for tubal
EP in LMICs is open salpingectomy [6,21,22]: many
tubal EPs have ruptured by the time women reach hos-
pital and/or a diagnosis has been made [6,21,23-29].
Reasons for this may include women’s unawareness of
being pregnant and underestimation of seriousness of
symptoms, as well as late diagnosis or misdiagnosis by
healthcare providers [21,30,31]. Assessments of delays
with seeking and receiving appropriate care, as applied
in maternal death reviews, are absent for women with
tubal EP in LMICs [3,32].
Papua New Guinea (PNG) is a LMIC situated north of
Australia with approximately seven million inhabitants
of Melanesian background [33]. Recent surveys confirm
a high fertility rate of 4.1-4.4 births per woman [34,35]
and maternal death is common [35-37]. Up-to-date in-
formation on EP in PNG is limited [38-43]. Sanga et al.
reported two maternal deaths due to tubal EP at a pro-
vincial referral hospital in the Highlands region, ac-
counting for 6.8% of all maternal deaths observed during
their study period (2005–2008) [38]. In the wider South
Pacific region, only one report from Vanuatu on inci-
dence and management of tubal EP in a population of
largely Melanesian background exists, which is 20 years
old [23].
This study aimed to evaluate the incidence, diagnosis
and clinical management of tubal ectopic pregnancy in a
provincial referral hospital in PNG.
Methods
Study design
This was a retrospective review of women with tubal EP
managed at Modilon General Hospital (MGH), Madang
Province, PNG, during the period 01/01/2008 – 31/08/
2012. The operating theatre register and gynaecology
ward admission book were used to identify patients who
had been booked for surgery for, or upon surgery were
diagnosed with, tubal EP. The emergency case register
was screened to identify potential tubal EP cases that
were not managed surgically. Through cross-comparison
with the hospital medical record registers additional
cases were identified. Women’s charts were subsequently
obtained and reviewed in detail.
Data collection
Demographic and clinical variables were extracted from
patients’ charts and entered into an Excel spreadsheet.
Information collected included demographic variables
such as age, ethnicity and area of residence, and data on
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case was allocated a unique identification number, ensur-
ing anonymisation in subsequent analysis. The labour ward
register was used to collect information on deliveries during
the study period.Data analysis
Data analysis was performed using Excel and STATA
version 10.0 (StataCorp, College Station, USA). Institu-
tional tubal EP rates were calculated per 1,000 births
(live births and stillbirths ≥ 24 weeks’ gestation) [12]. De-
lays were categorised according to the ‘three phases of
delay’ model [32]. Phase one delays were those with
clear evidence of a delay with seeking care. Phase two
delays included all women with delays in reaching the
health centre and/or hospital due to transport problems
or distance (including delays with transfers from health
centres to MGH). Phase three delays included all women
who had evidence of delays with receiving appropriate
care in a timely fashion – delays of this category were
analysed separately for health centres and hospital. Only
delays that could be identified beyond doubt using all
available documentation of individual patient journeys
were included. Written ethical approval for this review
was obtained from the MGH directorate.Results
A total of 91 possible tubal ectopic pregnancy cases were
identified during the study period. Case notes were avail-
able for 81 women of whom 73 had tubal ectopic preg-
nancies confirmed clinically at surgery (including 2
heterotopic pregnancies with tubal implantation). In
addition, there were three ovarian ectopic pregnancies,
and one chronic abdominal pregnancy (lithopaedion).
The institutional rate of tubal EP during the study
period was 6.3 per 1,000 deliveries, which equals 1 tubal
EP per 159 deliveries (Table 1). None of the 77 women
with confirmed ectopic pregnancy (any type) died. Four
cases were not EP: women underwent surgery for clin-
ical suspicion of EP but were subsequently confirmed to
have viable intrauterine pregnancies (n = 3) or ruptured
luteal cysts (n = 1).Table 1 Rates of tubal ectopic pregnancy at Modilon
General Hospital during the period 01 Jan 2008 – 31
Aug 2012
2008 2009 2010 2011 2012* Total
Tubal ectopic pregnancies 11 15 20 20 7 73
Total deliveries** 1708 2113 2763 2842 2141 11567
Rate (tubal ectopics only)*** 6.4 7.1 7.2 7.0 3.3 6.3
* 01/01/2012 – 31/08/2012 only; ** live births and stillbirths ≥ 24 weeks’
gestation; *** Number of ectopics/1,000 deliveries.Socio-demographic background of women with tubal
ectopic pregnancy
The mean age of women with tubal EP was 31.5 +/− 5.7years
(median = 31, range 15 – 45; n = 73) and the majority (95%;
69/73) were aged ≥ 25 years. Most women (93%; 62/67) were
married, three were in de facto relationships and two were
single. Forty-nine women (67%; 49/73) were rural dwellers.
Fifty-six women (79%; 56/71) belonged to ethnicities home
to Madang Province. Women’s employment and educational
status was documented poorly.
Clinical background and risk factors of patients with
tubal EP
The median parity was 2 (IQR = 1–3, mode: 1; range: 0–8;
n = 72): 11 (15%) women were nulliparous, 41 (56%) were
P1-2, 10 (14%) P3-4, and 10 (14%) were ≥ P5. Documenta-
tion of data was insufficient to calculate gestational age at
presentation. Forty-five women (62%) had evidence of sub-
fertility (defined as last childbirth ≥ 3 years ago, or being
nulliparous and having attempted to conceive for > 2 years).
Ten patients had a documented history of PID of whom
eight also had a history of sub-fertility, and three had a
history of STI. Six subjects had a tubal EP previously (all
managed through open salpingectomy), and five had
suffered miscarriage before. None of the women reported
prior use of an intrauterine contraceptive device. Smoking
status was only documented for 24 women – four were
smokers.
Clinical findings and management of tubal ectopic
pregnancy
The most common presenting complaint was abdominal
pain, followed by abnormal vaginal bleeding, and one
third of women had clinical evidence of shock (Table 2).
Pre-operative haemoglobin (Hb) levels ranged from 3.6 –
15.0 g/dL (mean 8.5, median 8.0) (n = 60), and one third
of patients had Hb levels of < 7 g/dL (n = 21). All 73
women with tubal EP underwent laparotomy under
general anaesthesia. Most tubal EPs were managed by
salpingectomy (n = 61/71); seven patients required a
salpingo-oophorectomy and three had partial myomecto-
mies for interstitial ectopics. Eleven patients simultan-
eously underwent ligation of the contralateral tube. There
was one case of peri-operative bowel injury. All patients
received peri- and postoperative broad-spectrum anti-
biotic cover as per national guideline [44]. Forty-nine
patients (64%) received blood transfusions: the median
number of units given was 2 (n = 32). Facilities for
autotranfusion and rhesus blood group testing were not
available at MGH during the study period.
Fourteen women had delays with discharge from hos-
pital due to post-operative pyrexia (n = 11), anaesthetic
complications (n = 2), and severe anaemia (n = 1). The
mean number of days from surgery until discharge was
Table 2 Common signs and symptoms observed amongst
women with tubal ectopic pregnancy (n = 73)
Investigation % (number)
Presenting complaints
Abdominal pain 98.6 (72)
Abnormal vaginal bleeding 60.3 (44)
Amenorrhoea 52.1 (38)
Syncope* 26.0 (19)
Findings upon examination
Guarding 56.2 (41)
Abdominal distension 43.8 (32)
Shock** 34.3 (25)
Rebound tenderness 32.9 (24)
Pyrexia 24.7 (18)
Pallor 23.3 (17)
Rigid abdomen 19.2 (14)
Abdominal mass 5.5 (4)
Bulging Pouch of Douglas 35.6 (26)
Cervical excitation 32.9 (24)
Adnexal tenderness 27.4 (20)
Adnexal mass 6.9 (5)
* Less common symptoms included nausea and vomiting, vaginal discharge,
shoulder tip pain, dysuria, pain on defaecation and shortness of breath.
** Defined as heart rate > 90 beats per minute and blood
pressure ≤ 90/60 mmHg.
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remaining fallopian tube hormonal contraception was
not prescribed, and information on subsequent concep-
tion success was unavailable.Operative findings
There were 39 left and 34 right tubal EPs. Information
on tubal location was available for 58 women: 25 EPs
were fimbrial, 24 were ampullary, 6 were isthmal and 3
were interstitial. Macroscopic evidence of pelvic infec-
tion, e.g. adhesions and hydrosalpinx, was noted in 31
women with tubal EP. Thirty-five women with tubal EPs
(48%) had evidence of rupture. They were more likely to
be rural dwellers (Fisher’s exact test, p = 0.023) com-
pared to women with unruptured EPs, but there was no
difference in parity (Mann–Whitney U test, p = 0.89)
and age (unpaired t-test, p = 0.22) between groups.
Intra-abdominal bleeding (any amount) was observed in
67 women (92%). When documented, estimated intra-
abdominal blood loss volume (haematoperitoneum)
ranged from 100 mls to 3000 mls (mean = 1331 mls,
median 1500 mls; n = 64). Two women had evidence of
endometriosis.Diagnosis and delays
Of 73 women with tubal EP, 34 (47%) were referrals
from other health centres and aid posts. Amongst them,
33 (97%) patients had documentation of a differential
diagnosis made at the referral centre: EP was considered
in 14 cases (42%). There was no use of pregnancy tests
at health centre level. Upon presentation to hospital, a
differential diagnosis made by junior medical staff was
documented for 47 (64%) patients: EP was considered
for 31 of these women (66%). Investigations undertaken
at MGH to aid diagnosis of tubal EP included culdocentesis
(most frequently used), urinary β-HCG, and ultrasound
(Table 3). Forty patients (55%) with tubal EP had evidence
of a delay with seeking healthcare (phase one delay). Four
patients had a phase two delay. Twenty-two and 27 patients
experienced a delay with receiving appropriate care and
treatment at referral centre and hospital, respectively.
Twenty-nine patients had more than one delay, and 12
(16%) had no delay at all. Typical phase three delays at
health centre level included patients not receiving necessary
treatment as per national guidelines, e.g. intravenous fluids
and antibiotics (n = 18) [44]. Misdiagnosis resulted in delays
with referral to MGH for four patients (patients with
suspected miscarriage were referred promptly). Phase three
delays at hospital level included delays with appropriate
management due to misdiagnosis (n = 14), delays with
receiving prompt surgery (n = 8), delays with blood transfu-
sion (n = 5), and delays with prompt medical review and
intra-hospital referral (n = 2).
Discussion
Ectopic pregnancy is a common gynaecological emer-
gency at a provincial referral hospital in coastal PNG: we
counted 6.3 tubal EPs per 1,000 deliveries at MGH. Al-
though maternal deaths due to EP were not observed,
morbidity was high: the majority of patients with tubal
EP had significant intra-abdominal bleeding, half of
them had evidence of tubal rupture, and one-third of
patients were in hypovolaemic shock on arrival. All
patients with tubal EP were managed by open salpingec-
tomy, and two-thirds received blood transfusion peri- or
postoperatively. Women residing in rural areas were
more likely to have a ruptured tubal EP. This requires
consideration at several levels.
The institutional rate of tubal EP provides an insight
into the burden of EP in PNG, but cannot be used to de-
termine overall regional incidence. It is likely that pro-
portionally more ectopic pregnancies ‘occur’ at a referral
hospital, and the overall regional rate may be lower. For
instance, if only direct hospital presentations were in-
cluded, the EP rate would halve. Furthermore, 16 of 37
of non-referrals were residing in distant rural areas.
However, this may be offset in part by those EPs that
may go undetected in rural areas, in particular in view of
Table 3 Investigations performed to aid diagnosis of ectopic pregnancy (n = 81; all suspected cases with charts)
Investigation All suspected
cases
Women with tubal ectopic
pregnancy
Women with extra-tubular ectopic
pregnancy
Women with no ectopic
pregnancy
(n = 81) (n = 73) (n = 4) (n = 4)
Culdocentesis; % (n) 88.9 (72/81) 89.0 (65/73) 75.0 (3/4) 100.0 (4/4)
Positive; % (n) 88.9 (64/72) 92.3 (60/65) 66.7 (2/3) 50.0 (2/4)
β-HCG*; % (n) 65.4 (53/81) 65.8 (48/73) 25.0 (1/4) 100.0 (4/4)
Positive; % (n) 94.3 (50/53) 95.8 (46/48) 100.0 (1/1) 75.0 (3/4)
Ultrasound**; % (n) 39.5 (32/81) 39.7 (29/73) 50.0 (2/4) 25.0 (1/4)
Positive; % (n) 93.8 (30/32) 96.6 (28/29) 100.0 (2/2) 0.0 (0/1)
* urinary human chorionic gonadotrophin ** extra-uterine gestational sac and/or free intra-abdominal fluid.
Hamura et al. BMC Pregnancy and Childbirth 2013, 13:86 Page 5 of 8
http://www.biomedcentral.com/1471-2393/13/86the low rate of clinical suspicion observed at health
posts. By the time hospital was reached, many women
were already suffering haemodynamic compromise: this
raises concerns about women dying from EP without
ever reaching a healthcare facility. EP has been observed
to be a cause of early maternal death in other areas in
PNG, and it is possible that its overall contribution to ma-
ternal deaths in PNG and other LMICs is underestimated
[38]. In addition, case notes were unavailable for ten poten-
tial cases of EP. Our institutional rate is similar to most
rates observed in LMICs in Asia [11,13], but lower
compared to rates reported from Europe and Africa
[9,21,31,45-48]. Underdetection of cases and differences in
the frequency and distribution of risk factors for tubal EP
are likely to be implicated.
Delays with presentation to a healthcare provider
(health centre or hospital) were common, and may have
contributed to the high proportion of women with tubal
rupture. The distribution of phase one delays between
rural and urban dwellers was similar (data not shown),
and root causes for late presentation remain unclear. It
is possible that women may be unaware of their preg-
nancy status and pregnancy-related complications, or
indeed may hesitate to seek help as they find it difficult
to raise funds for health centre visits. The number of
clearly identifiable phase two delays in our study was
low; however, rural dwellers were more likely to suffer
tubal rupture. It is therefore possible that phase two de-
lays were underestimated, due to intrinsic constraints of
retrospective case note reviews. Phase three delays
included problems with diagnosis: at health centre level
pregnancy test kits were not used (possibly due to
unavailability) which may have increased the time until a
diagnosis was made and referral was arranged. At hos-
pital level, diagnostic tools were more readily available
and aided diagnosis in the majority of cases (Table 3).
The high proportion of women where EP was not
suspected as part of the initial differential diagnosis is
concerning. Interventions to increase health workers’
awareness of EP are of utmost importance. Delays with
timely transfusion and prompt surgery were also noted,pointing towards the need to increase laboratory and op-
erative capacity in referral hospitals. Autotransfusion
could be one approach to reduce the number of donated
units of blood required [29].
Culdocentesis is frequently used, and together with
pregnancy test kits is likely to remain the main diagnos-
tic tool to complement clinical history and examination
in PNG in the short term. Ultrasound is gradually intro-
duced but its application is limited by cost and lack of
trained staff. In the longer term, research into identifying
serum biomarkers for the rapid diagnosis of tubal EP is
important. Such a biomarker could provide clinical staff
working in low-resource environments with a simple
rapid bedside diagnostic test, aiding prompt diagnosis
and management and reducing morbidity and healthcare
costs [49,50]. However, its potential success would still
rely on clinical suspicion of EP and functioning supply
chains ensuring adequate distribution, the latter yet un-
attainable for pregnancy test kits.
For most women in PNG, the clinical course of tubal
EP would preclude medical management with metho-
trexate. Facilities for laparoscopic surgery were unavail-
able at MGH, but its introduction could aid diagnosis
and reduce post-operative recovery time and morbidity.
Nevertheless, at least one third of patients were in
haemodynamic shock, and laparotomy was the oper-
ation of choice. This echoes findings from research
conducted in other LMICs [13,20,45,47]. Equally, the
role of salpingotomy may be limited – most women
with EP were parous, tubal rupture was common, and
tubal preservation may not be viewed as a major clin-
ical concern in this patient population (yet).
There is evidence that the prevalence of STIs, includ-
ing C. trachomatis and N.gonorrhoeae, is high in PNG
[51,52]. In addition, in PNG early sexual debut and low
condom use increase the risk of STIs [53]. Although
only ten patients had a documented history of PID in
this review, 31 (43%) had macroscopic evidence of PID
at surgery and 62% (n = 45) of women with tubal EP had
a history of subfertility. It is likely that PID represents an
important risk factor for tubal EP in PNG and similar
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ments [14,45]. Early sexual debut and low uptake of
contraception may in part explain that the majority of
women (85%) with tubal EP were parous. It remains un-
clear however, why the mean age of patients with tubal
EP (31.5 years) is comparatively higher compared to
other studies from LMICs [25,26,47,54-56]. Another po-
tentially important risk factor may be tobacco smoking.
In this study there were only four women who smoked;
however, documentation of smoking habit was lacking
for 67% of patients. Smoking may become an increas-
ingly important risk factor for tubal EP in PNG given
the fact that the number of women who smoke is rising
[17]. Lastly, betel nut (Areca catechu L.) consumption
amongst pregnant women in Madang Province is com-
mon and known to increase the risk of adverse preg-
nancy outcomes [57]. A possible association between
this habit, tubal damage and an increased risk of EP has
not been examined yet. Case notes used in this study did
not contain information on betel nut consumption.
The PNG manual of standard managements in obstet-
rics and gynaecology is a highly useful resource for
health workers in PNG [44], and it includes guidelines
for the management of EP. Hormonal contraception for
a minimum of six months is recommended for patients
with a remaining tube following surgery. However, none
of the relevant cases in this review were managed
accordingly. Equally, when EP is suspected, fluid resusci-
tation prior to referral to hospital is advocated, but this
was frequently not done. It is unclear as to whether this
was due a lack of resources, or guidelines were
not followed. Lastly, haematinic supplementation is
recommended upon discharge, but was commonly not
described (data not shown) [44]. Wide distribution of
the manual, concomitant training and adequate med-
ical supply chains are required to ensure optimal man-
agement of EP in PNG.
This review has identified areas of further research. A
prospective institutional case–control study can assist
with confirming demographic and clinical risk factors
for tubal EP in PNG, and could be combined with STI
screening. In addition, such study could examine the
sensitivity and specificity of currently available diagnostic
aids (namely culdocentesis and urinary β-HCG) in the
PNG clinical environment: we identified four women
with negative findings on laparotomy, yet two of them
had a positive culdocentesis (Table 3). Such cases need
to be reviewed when they occur to assess whether they
could have been prevented through appropriate use of
clinical history and examination and currently available
diagnostic aids. Semi-structured interviews with women
diagnosed with tubal EP will clarify the root causes of
potential delays experienced (in particular phase one
and phase three delays). The role of family andcommunity care to improve diagnosis and prompt man-
agement of EP could be evaluated simultaneously [58].
Detailed post-mortem examinations of women who died
at reproductive age are required to understand the con-
tribution of EP to maternal mortality; however, facilities
for this are currently unavailable at MGH, and this may
not be applicable to women who died in distant rural
communities. Here, qualitative research methodology
may help identify EP as a potential cause of death. In
addition, this study has shown that EP is frequently not
suspected as a potential diagnosis – a survey on know-
ledge and awareness amongst health workers may iden-
tify needs for further training. Lastly, and perhaps most
importantly, research into knowledge, beliefs, attitudes
and practices relating to family planning, conception
and early pregnancy amongst women of reproductive
age needs to be conducted: it is possible that many are
not aware of being pregnant [21], and delays with pres-
entation increase the risk of tubal rupture, reduce the
window of opportunity for medical management and en-
hance the risk of morbidity and mortality.
There are several limitations to the study. First, notes
for ten potential (yet unconfirmed) cases were unavail-
able for review. This could result in underestimation of
the institutional tubal EP rate. Second, the review was
based on case note data alone, and is therefore subject
to documentation bias. In particular, socio-economic pa-
tient background data was poorly documented. Third,
documentation of the patient journey was not always de-
tailed enough to detect a delay – only delays clearly
identifiable from case notes were included and the true
number of delays may be underestimated, in particular
phase two delays. Furthermore, when delays were
detected we were not always able to identify the root
cause(s) of the delay. For instance, it was unclear why
some patients did not receive antibiotics and/or intra-
venous fluids at some health centres: inadequate stocks,
misdiagnosis and suboptimal management are all pos-
sible explanations. Lastly, it is possible that EPs causing
maternal death may have been missed. One of the ten
patients’ cases notes that were unavailable belonged to a
young woman who collapsed on arrival at MGH and
died – a differential diagnosis of ectopic pregnancy was
provided, but could not be substantiated through docu-
mentation of a positive pregnancy test result or autopsy
findings.
Conclusions
Tubal EP is a common gynaecological emergency in a
provincial referral hospital in coastal PNG, and causes
significant maternal morbidity. Most women had evi-
dence of intra-abdominal bleeding, and tubal rupture
was common, in particular amongst patients from rural
areas. Clinical suspicion of EP at aid posts was low, and
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underused or not available at these sites. Macroscopic
evidence of pelvic infection was common and the preva-
lence of STIs in PNG is high [52] – this points towards
STIs as the most important risk factor for tubal EP in
PNG. In addition to preventing, detecting and treating
STIs, interventions to reduce morbidity (and mortality)
include family planning and the identification and reduc-
tion of barriers to early presentation. Increasing health
workers’ knowledge of the condition, and providing
them with simple clinical and diagnostic tools (in par-
ticular pregnancy test kits) will improve diagnosis and
referral. At hospital level, prompt review and diagnosis
of cases, and strengthening operating and transfusion
capacities will reduce morbidity.
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